Center for Scientific Review; Notice of Closed Meetings, 14142-14143 [2015-06121]
Download as PDF
<![CDATA[
14142
Federal Register / Vol. 80, No. 52 / Wednesday, March 18, 2015 / Notices
treatment for more aggressive cancers
versus non aggressive treatment.
Competitive Advantages: The PCR
based method is more advantageous and
more objective than currently available
histological classification and staging
systems.
Development Stage:
• Early-stage.
• In vitro data available.
• In vivo data available (human).
Inventors: Guiseppe Giaccone and
Yisong Wang (NCI).
Publication: Petrini I, et al. A specific
missense mutation in GTF2I occurs at
high frequency in thymic epithelial
tumors. Nat Genet. 2014 Aug;46(8):844–
9. [PMID 24974848].
Intellectual Property: HHS Reference
No. E–109–2014/0—US Provisional
Application No. 61/975,222 filed April
4, 2014.
Licensing Contact: Sabarni Chatterjee,
Ph.D., MBA; 301–435–5587;
chatterjeesa@mail.nih.gov.
Collaborative Research Opportunity:
For collaboration opportunities, please
contact Dr. Guiseppe Giaccone at
gg496@georgetown.edu.
mstockstill on DSK4VPTVN1PROD with NOTICES
Systems and Devices for Training and
Imaging an Awake Test Animal
Description of Technology: The
invention pertains to an apparatus and
training system for rodents to maintain
its head substantially motionless during
an imaging procedure. The system
includes a frame defining an enclosure
for enclosing an animal therein during
the imaging procedure which has a head
post attached to the head of the animal
and a treadmill having a plurality of
rollers that the animal walks on such
that one or more of the plurality of
wheels rotate when the animal is in
walking motion and stop rotating when
the animal is in a substantially
motionless state. This arrangement
trains the animal to remain substantially
motionless when disposed within an
imaging apparatus. This invention
permits prolonged imaging of awake
rodents with minimal confinement and
reduces stress.
Potential Commercial Applications:
• Imaging test rodents.
• Imaging pharmacological agent
distribution in rodents.
• Imaging the therapeutically effects
of pharmacological agent.
Competitive Advantages: Imaging
while animal is awake.
Development Stage:
• Early-stage.
• Prototype.
Inventors: Hanbing Lu, Yihong Yang,
Elliot Stein (all of NIDA).
Intellectual Property: HHS Reference
No. E–043–2015/0—US Patent
VerDate Sep<11>2014
19:00 Mar 17, 2015
Jkt 235001
Application 14/589,725 filed January 5,
2015.
Licensing Contact: Michael
Shmilovich; 301–435–5019; shmilovm@
mail.nih.gov.
Collaborative Research Opportunity:
The National Institute on Drug Abuse is
seeking statements of capability or
interest from parties interested in
collaborative research to further develop
apparatus and/or the training system;
commercialize with pharmaceutical
industry. For collaboration
opportunities, please contact Vio
Conley, M.S. at conleyv@mail.nih.gov.
Miniature System for Manipulating
Small Animals in High-Throughput
Screening Small Molecules
Description of Technology: The
invention pertains to a miniaturized
plating and feeding system based on a
96-well microplate base and is intended
to reduce manipulation of organisms as
well as amounts of test drug/anesthetic,
thereby mitigating waste. The kit
comprises a feeder plate, transfer
adaptor and receiver plate. The feeder
plate is defined by, for example, a
plastic 96-well plate with rounded
wells. The rounded bottoms can
dispense to or permit access to the test
organism of liquid food or drug through
about 7 holes of approximately 350
microns in diameter. A top portion of
the well provides test organisms (e.g.,
drosophila, daphnia) with sufficient
space to enjoy normal life-cycles
without confinement stress. The feeder
plate includes means for interfacing
with complementary components of the
transfer and receiver plates through
receiving holes and complementary
dowels or pins. A transfer adapter
allows the interconnection of the feeder
plate to the receiver plate. The transfer
plate can be configured to be square or
rounded for the transfer of organisms
from the feeder plate to the receiver
plate.
Potential Commercial Applications:
• Drug Development.
• Toxicity Studies.
• Drug Design.
Competitive Advantages:
• Small animals.
• High Throughput.
• Space efficiency.
• Resource economy.
Development Stage:
• Early stage.
• Prototype.
Inventors: Maria De Los Angeles Jaime
and Brian Oliver (NIDDK).
Intellectual Property: HHS Reference
No. E–034–2015/0—US Provisional
Application No. 62/080,181 filed
November 14, 2014.
PO 00000
Frm 00073
Fmt 4703
Sfmt 4703
Licensing Contact: Michael
Shmilovich, Esq.; 301–435–5019;
shmilovm@mail.nih.gov.
Collaborative Research Opportunity:
The National Institute of Diabetes and
Digestive and Kidney Diseases is
seeking statements of capability or
interest from parties interested in
collaborative research to further
develop, evaluate or commercialize
High-Throughput Small Animal
Manipulation for Drug Design. For
collaboration opportunities, please
contact Marguerite J. Miller at
millermarg@niddk.nih.gov.
This abstract replaces one published
on Thursday, January 29, 2015 (80 FR
4935) to correct the patent application
filing date.
Dated: March 12, 2015.
Richard U. Rodriguez, M.B.A.,
Acting Director, Office of Technology
Transfer, National Institutes of Health.
[FR Doc. 2015–06123 Filed 3–17–15; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of
Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; PAR Panel:
Cancer Health Disparities/Diversity in Basic
Cancer Research.
Date: April 13–14, 2015.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Embassy Suites at the Chevy Chase
Pavilion, 4300 Military Road, NW.,
Washington, DC 20015.
Contact Person: Nywana Sizemore, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 6204,
MSC 7804, Bethesda, MD 20892, 301–435–
1718, sizemoren@csr.nih.gov.
E:\FR\FM\18MRN1.SGM
18MRN1
Federal Register / Vol. 80, No. 52 / Wednesday, March 18, 2015 / Notices
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Program
Project: National Biomedical NMR Resource.
Date: April 13–15, 2015.
Time: 7:00 p.m. to 12:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Doubletree Hotel Bethesda,
(Formerly Holiday Inn Select), 8120
Wisconsin Avenue, Bethesda, MD 20814.
Contact Person: Michael Eissenstat, Ph.D.,
Scientific Review Officer, BCMB IRG, Center
for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4166,
Bethesda, MD 20892, 301–435–1722,
eissenstatma@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflict: AIDS and AIDS Related Research.
Date: April 13, 2015.
Time: 12:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892,
(Telephone Conference Call).
Contact Person: Eduardo A Montalvo,
Ph.D., Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5108,
MSC 7852, Bethesda, MD 20892, (301) 435–
1168, montalve@csr.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
Dated: March 12, 2015.
Carolyn A. Baum,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2015–06121 Filed 3–17–15; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
mstockstill on DSK4VPTVN1PROD with NOTICES
Center for Scientific Review; Notice of
Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; PAR–14–
VerDate Sep<11>2014
19:00 Mar 17, 2015
Jkt 235001
14143
085: Metabolic Reprogramming in
Immunotherapy.
Date: March 17, 2015.
Time: 1:30 p.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892,
(Telephone Conference Call).
Contact Person: Denise R Shaw, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 6158,
MSC 7804, Bethesda, MD 20892, 301–435–
0198, shawdeni@csr.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
the collection of information on those
who are to respond, including through
the use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submission of
responses; and (e) Assess information
collection costs.
To request additional information on
the proposed project or to obtain a copy
of the information collection plan and
instruments, call (404) 639–7570 or
send an email to omb@cdc.gov. Written
comments and/or suggestions regarding
the items contained in this notice
should be directed to the Attention:
CDC Desk Officer, Office of Management
and Budget, Washington, DC 20503 or
by fax to (202) 395–5806. Written
comments should be received within 30
days of this notice.
Dated: March 12, 2015.
Carolyn A. Baum,
Program Analyst, Office of Federal Advisory
Committee Policy.
Proposed Project
Coal Workers’ Health Surveillance
Program (CWHSP)—(0920–0020)—
Reinstatement with Change—National
Institute for Occupational Safety and
Health (NIOSH), Centers for Disease
Control and Prevention (CDC).
[FR Doc. 2015–06120 Filed 3–17–15; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[30Day–15–0020]
Agency Forms Undergoing Paperwork
Reduction Act Review
The Centers for Disease Control and
Prevention (CDC) has submitted the
following information collection request
to the Office of Management and Budget
(OMB) for review and approval in
accordance with the Paperwork
Reduction Act of 1995. The notice for
the proposed information collection is
published to obtain comments from the
public and affected agencies.
Written comments and suggestions
from the public and affected agencies
concerning the proposed collection of
information are encouraged. Your
comments should address any of the
following: (a) Evaluate whether the
proposed collection of information is
necessary for the proper performance of
the functions of the agency, including
whether the information will have
practical utility; (b) Evaluate the
accuracy of the agencies estimate of the
burden of the proposed collection of
information, including the validity of
the methodology and assumptions used;
(c) Enhance the quality, utility, and
clarity of the information to be
collected; (d) Minimize the burden of
PO 00000
Frm 00074
Fmt 4703
Sfmt 4703
Background and Brief Description
NIOSH would like to submit an
Information Collection Request (ICR) to
revise the data collection instruments
being utilized within the Coal Workers’
Health Surveillance Program (CWHSP).
On May 1, 2014, the Mine Safety and
Health Administration (MSHA)
published final rule 30 CFR 70, 71, 72,
75, and 90. The new MSHA rule added
surface coal miners, a respiratory health
assessment, and spirometry testing for
chronic obstructive pulmonary disease
(COPD) to the previously mandated
chest x-ray examination program. These
additions are being referred to as the
Expanded CWHSP (an additional
component under the current CWHSP).
This request incorporates all
components that now fall under the
CWHSP. Those components include:
Coal Workers’ X-ray Surveillance
Program (CWXSP), B Reader Program,
Enhanced Coal Workers’ Health
Surveillance Program (ECWHSP),
Expanded Coal Workers’ Health
Surveillance Program, and National
Coal Workers’ Autopsy Study (NCWAS).
The CWHSP is a congressionallymandated medical examination program
for monitoring the health of coal miners.
The Program was originally authorized
under the 1969 Federal Coal Mine
Health and Safety Act and is currently
authorized under the 1977 Federal Mine
Safety and Health Act and its
subsequent amendments (the Act). The
Act provides the regulatory authority for
E:\FR\FM\18MRN1.SGM
18MRN1
]]>Agencies
[Federal Register Volume 80, Number 52 (Wednesday, March 18, 2015)]
[Notices]
[Pages 14142-14143]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2015-06121]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of Closed Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is hereby given of the following
meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: Center for Scientific Review Special Emphasis
Panel; PAR Panel: Cancer Health Disparities/Diversity in Basic
Cancer Research.
Date: April 13-14, 2015.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: Embassy Suites at the Chevy Chase Pavilion, 4300 Military
Road, NW., Washington, DC 20015.
Contact Person: Nywana Sizemore, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 6204, MSC 7804, Bethesda, MD
20892, 301-435-1718, sizemoren@csr.nih.gov.
[[Page 14143]]
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Program Project: National Biomedical NMR Resource.
Date: April 13-15, 2015.
Time: 7:00 p.m. to 12:00 p.m.
Agenda: To review and evaluate grant applications.
Place: Doubletree Hotel Bethesda, (Formerly Holiday Inn Select),
8120 Wisconsin Avenue, Bethesda, MD 20814.
Contact Person: Michael Eissenstat, Ph.D., Scientific Review
Officer, BCMB IRG, Center for Scientific Review, National Institutes
of Health, 6701 Rockledge Drive, Room 4166, Bethesda, MD 20892, 301-
435-1722, eissenstatma@csr.nih.gov.
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Member Conflict: AIDS and AIDS Related Research.
Date: April 13, 2015.
Time: 12:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892, (Telephone Conference Call).
Contact Person: Eduardo A Montalvo, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5108, MSC 7852, Bethesda, MD
20892, (301) 435-1168, montalve@csr.nih.gov.
(Catalogue of Federal Domestic Assistance Program Nos. 93.306,
Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393-93.396, 93.837-93.844, 93.846-93.878, 93.892, 93.893,
National Institutes of Health, HHS)
Dated: March 12, 2015.
Carolyn A. Baum,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2015-06121 Filed 3-17-15; 8:45 am]
BILLING CODE 4140-01-P
